trending Market Intelligence /marketintelligence/en/news-insights/trending/_lGnZaI0v2hUeTml8-_SRw2 content esgSubNav
In This List

Eyegate Pharmaceuticals CFO resigns

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Eyegate Pharmaceuticals CFO resigns

Ryan Brenneman is no longer Eyegate Pharmaceuticals Inc.'s CFO and principal financial and accounting officer.

Brenneman resigned from the positions, prompting company President and CEO Stephen From to assume the role of principal financial and accounting officer.